Centerpulse passes deadline with no appeal
This article was originally published in Clinica
Executive Summary
No patients have appealed against Swiss company Centerpulse's $1bn class action settlement over faulty hip and knee implants. There was a one-month period when patients could appeal the court's approval of the settlement, reached last month, and no such appeal has been received, the company says.